financetom
Business
financetom
/
Business
/
--Heartland Express Keeps Quarterly Dividend at $0.02 a Share, Payable April 5 to Shareholders of Record March 26
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Heartland Express Keeps Quarterly Dividend at $0.02 a Share, Payable April 5 to Shareholders of Record March 26
Mar 15, 2024 7:34 AM

10:11 AM EDT, 03/15/2024 (MT Newswires) --

Price: 11.94, Change: -0.01, Percent Change: -0.10

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
InterContinental Hotels Group's Q3 Global Revenue per Available Room Increases
InterContinental Hotels Group's Q3 Global Revenue per Available Room Increases
Oct 22, 2024
06:27 AM EDT, 10/22/2024 (MT Newswires) -- InterContinental Hotels Group ( IHG ) reported Tuesday a 1.5% increase in Q3 global revenue per available room compared with the same period last year. The Americas saw a 1.7% sales increase, while the EMEA region increased by 4.9%, driven by continued growth in the US. Greater China reported a 10.3% decline due...
--Medpace Guides For 2024 GAAP EPS of $11.71-$12.09 on Revenue of $2.09-$2.13 Billion, vs CIQ Analyst Consensus of $11.56/Share on Revenue of $2.14 Billion
--Medpace Guides For 2024 GAAP EPS of $11.71-$12.09 on Revenue of $2.09-$2.13 Billion, vs CIQ Analyst Consensus of $11.56/Share on Revenue of $2.14 Billion
Oct 22, 2024
04:17 PM EDT, 10/21/2024 (MT Newswires) -- Price: 326.64, Change: -26.28, Percent Change: -7.45 ...
goeasy Upsizes, Prices Offering of Senior Unsecured Notes
goeasy Upsizes, Prices Offering of Senior Unsecured Notes
Oct 22, 2024
06:24 AM EDT, 10/22/2024 (MT Newswires) -- goeasy (GSY.TO), a Canadian consumer lender, late on Monday said it has priced US$400 million of 6.875% senior unsecured notes due 2030, up from US$350 million previously, and C$150 million of 6% senior unsecured notes due 2030. The company also expects to enter into a currency swap agreement to fix the foreign currency...
US FDA declines to approve Camurus' rare hormone disorder drug
US FDA declines to approve Camurus' rare hormone disorder drug
Oct 22, 2024
Oct 22 (Reuters) - The U.S. Food and Drug Administration has declined to approve Camurus' drug for the treatment of a rare hormonal disorder due to deficiencies at a third-party manufacturing facility, the Swedish drugmaker said late Monday. WHY IT'S IMPORTANT The FDA's decision could delay the approval and subsequent launch of the drug, CAM2029, meant to treat patients with...
Copyright 2023-2025 - www.financetom.com All Rights Reserved